Dendritic cells respond to nasopharygeal carcinoma cells through annexin A2-recognizing DC-SIGN

Oncotarget

Volumn 6, Issue 1, 2015, Pages 159-170

  Chao, Pin Zhir ^a,b   Hsieh, Ming Shium ^a,c   Cheng, Chao Wen ^a   Hsu, Tin Jui ^d   Lin, Yun Tien ^d   Lai, Chang Hao ^d   Liao, Chen Chung ^e   Chen, Wei Yu ^f   Leung, Ting Kai ^g   Lee, Fei Peng ^f   Lin, Yung Feng ^d   Chen, Chien Ho ^d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c EN CHU KONG HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Annexin A2; DC SIGN; Dendritic cell; IL 10; Immunosuppression; NPC

Indexed keywords

CD209 ANTIGEN; INTERLEUKIN 10; LECTIN; LIPOCORTIN 2; ANXA2 PROTEIN, HUMAN; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; CYTOKINE; DC-SPECIFIC ICAM-3 GRABBING NONINTEGRIN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 12; LIGAND; POLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BINDING AFFINITY; CARCINOMA CELL; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPRECIPITATION; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; CHEMISTRY; CYTOLOGY; GENE EXPRESSION REGULATION; IMMUNOTHERAPY; METABOLISM; NASOPHARYNX TUMOR; NONOBESE DIABETIC MOUSE; PROCEDURES; RNA INTERFERENCE; SCID MOUSE; TUMOR CELL LINE;

ANIMALS; ANNEXIN A2; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CYTOKINES; DENDRITIC CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN G; IMMUNOPRECIPITATION; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY; INTERLEUKIN-10; INTERLEUKIN-12; LECTINS, C-TYPE; LIGANDS; MICE; MICE, INBRED NOD; MICE, SCID; NASOPHARYNGEAL NEOPLASMS; NEOPLASM TRANSPLANTATION; POLYSACCHARIDES; RECEPTORS, CELL SURFACE; RNA INTERFERENCE;

EID: 84921396564     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2700     Document Type: Article

References (36)

1. Radford KJ, Tullett KM and Lahoud MH. Dendritic cells and cancer immunotherapy. Curr Opin Immunol. 2014; 27:26-32.
2. Lanzavecchia A and Sallusto F. Regulation of T cell immunity by dendritic cells. Cell. 2001; 106(3):263-266.
3. Geijtenbeek TB, van Vliet SJ, Engering A, t Hart BA and van Kooyk Y. Self-and nonself-recognition by C-type lectins on dendritic cells. Annu Rev Immunol. 2004; 22:33-54.
4. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, Cornelissen IL, Nottet HS, KewalRamani VN, Littman DR, Figdor CG and van Kooyk Y. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell. 2000; 100(5):587-597.
5. den Dunnen J, Gringhuis SI and Geijtenbeek TB. Innate signaling by the C-type lectin DC-SIGN dictates immune responses. Cancer immunology, immunotherapy: CII. 2009; 58(7):1149-1157.
6. Hsu SC, Chen CH, Tsai SH, Kawasaki H, Hung CH, Chu YT, Chang HW, Zhou Y, Fu J, Plunkett B, Su SN, Vieths S, Lee RT, Lee YC and Huang SK. Functional interaction of common allergens and a C-type lectin receptor, dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN), on human dendritic cells. J Biol Chem. 2010; 285(11):7903-7910.
7. Svajger U, Anderluh M, Jeras M and Obermajer N. C-type lectin DC-SIGN: an adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity. Cell Signal. 2010; 22(10):1397-1405.
8. Grutz G. New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. J Leukoc Biol. 2005; 77(1):3-15.
9. Vicari AP, Caux C and Trinchieri G. Tumour escape from immune surveillance through dendritic cell inactivation. Seminars in cancer biology. 2002; 12(1):33-42.
10. Aarnoudse CA, Garcia Vallejo JJ, Saeland E and van Kooyk Y. Recognition of tumor glycans by antigen-presenting cells. Curr Opin Immunol. 2006; 18(1):105-111.
11. Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M and Geijtenbeek TB. Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat Immunol. 2009; 10(10):1081-1088.
12. Saeland E, Belo AI, Mongera S, van Die I, Meijer GA and van Kooyk Y. Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients. International journal of cancer Journal international du cancer. 2012; 131(1):117-128.
13. Nonaka M, Ma BY, Imaeda H, Kawabe K, Kawasaki N, Hodohara K, Kawasaki N, Andoh A, Fujiyama Y and Kawasaki T. Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) recognizes a novel ligand, Mac-2-binding protein, characteristically expressed on human colorectal carcinomas. J Biol Chem. 2011; 286(25):22403-22413.
14. van Gisbergen KP, Aarnoudse CA, Meijer GA, Geijtenbeek TB and van Kooyk Y. Dendritic cells recognize tumorspecific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin. Cancer Res. 2005; 65(13):5935-5944.
15. van Kooyk Y and Geijtenbeek TB. DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol. 2003; 3(9):697-709.
16. Xu T, Tang J, Gu M, Liu L, Wei W and Yang H. Recurrent nasopharyngeal carcinoma: a clinical dilemma and challenge. Current oncology. 2013; 20(5):e406-419.
17. Giannini A, Bianchi S, Messerini L, Gallo O, Gallina E, Asprella Libonati G, Olmi P and Zampi G. Prognostic significance of accessory cells and lymphocytes in nasopharyngeal carcinoma. Pathol Res Pract. 1991; 187(4):496-502.
18. Zong YS, Zhang CQ, Zhang F, Ruan JB, Chen MY, Feng KT and Yu ZF. Infiltrating lymphocytes and accessory cells in nasopharyngeal carcinoma. Japanese journal of cancer research: Gann. 1993; 84(8):900-905.
19. Hartmann E, Wollenberg B, Rothenfusser S, Wagner M, Wellisch D, Mack B, Giese T, Gires O, Endres S and Hartmann G. Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Cancer Res. 2003; 63(19):6478-6487.
20. Xu YF, Liu WL, Dong JQ, Liu WS, Feng QS, Chen LZ, Zeng YX, Zeng MS and Jia WH. Sequencing of DCSIGN promoter indicates an association between promoter variation and risk of nasopharyngeal carcinoma in cantonese. BMC Med Genet. 2010; 11:161.
21. Waisman DM. Annexin II tetramer: structure and function. Mol Cell Biochem. 1995; 149-150:301-322.
22. Bharadwaj A, Bydoun M, Holloway R and Waisman D. Annexin A2 heterotetramer: structure and function. International journal of molecular sciences. 2013; 14(3):6259-6305.
23. Zhang X, Liu S, Guo C, Zong J and Sun MZ. The association of annexin A2 and cancers. Clin Transl Oncol. 2012; 14(9):634-640.
24. Goulet F, Moore KG and Sartorelli AC. Glycosylation of annexin I and annexin II. Biochem Biophys Res Commun. 1992; 188(2):554-558.
25. Woodham AW, Raff AB, Raff LM, Da Silva DM, Yan L, Skeate JG, Wong MK, Lin YG and Kast WM. Inhibition of Langerhans cell maturation by human papillomavirus type 16: a novel role for the annexin A2 heterotetramer in immune suppression. J Immunol. 2014; 192(10):4748-4757.
26. Nonaka M, Ma BY, Murai R, Nakamura N, Baba M, Kawasaki N, Hodohara K, Asano S and Kawasaki T. Glycosylation-Dependent Interactions of C-Type Lectin DC-SIGN with Colorectal Tumor-Associated Lewis Glycans Impair the Function and Differentiation of Monocyte-Derived Dendritic Cells. The Journal of Immunology. 2008; 180(5):3347-3356.
27. Luo M and Hajjar KA. Annexin A2 system in human biology: cell surface and beyond. Seminars in thrombosis and hemostasis. 2013; 39(4):338-346.
28. Dong Z, Yao M, Zhang H, Wang L, Huang H, Yan M, Wu W and Yao D. Inhibition of Annexin A2 gene transcription is a promising molecular target for hepatoma cell proliferation and metastasis. Oncology letters. 2014; 7(1):28-34.
29. Ozyar E, Ayhan A, Korcum AF and Atahan IL. Prognostic role of Ebstein-Barr virus latent membrane protein-1 and interleukin-10 expression in patients with nasopharyngeal carcinoma. Cancer investigation. 2004; 22(4):483-491.
30. Beck A, Pazolt D, Grabenbauer GG, Nicholls JM, Herbst H, Young LS and Niedobitek G. Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease. The Journal of pathology. 2001; 194(2):145-151.
31. Fiorentino DF, Bond MW and Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 1989; 170(6):2081-2095.
32. Heidt S, Segundo DS, Chadha R and Wood KJ. The impact of Th17 cells on transplant rejection and the induction of tolerance. Curr Opin Organ Transplant. 2010; 15(4):456-461.
33. Chang J, Kunkel SL and Chang CH. Negative regulation of MyD88-dependent signaling by IL-10 in dendritic cells. Proc Natl Acad Sci U S A. 2009; 106(43):18327-18332.
34. Martin M, Leffler J and Blom AM. Annexin A2 and A5 serve as new ligands for C1q on apoptotic cells. J Biol Chem. 2012; 287(40):33733-33744.
35. Hosszu KK, Valentino A, Vinayagasundaram U, Vinayagasundaram R, Joyce MG, Ji Y, Peerschke EI and Ghebrehiwet B. DC-SIGN, C1q, and gC1qR form a trimolecular receptor complex on the surface of monocytederived immature dendritic cells. Blood. 2012; 120(6):1228-1236.
36. Lin CT, Wong CI, Chan WY, Tzung KW, Ho JK, Hsu MM and Chuang SM. Establishment and characterization of two nasopharyngeal carcinoma cell lines. Laboratory investigation; a journal of technical methods and pathology. 1990; 62(6):713-724.